Cargando…

Acarbose improves glycemic control and reduces body weight: Subanalysis data of South Asia region

Alpha-glucosidase inhibitors (AGIs) are widely used especially in Asian countries as a treatment option for type 2 diabetes patients with high postprandial glycaemia. However, data from South Asia region is very limited. In order to examine the effect of AGI in real-life setting, 10 PMS/NIS from all...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalra, S, Sahay, R. K., Schnell, O., Sheu, W.H.H., Grzeszczak, W., Watada, H., Soegondo, S., Yamamoto, N., Weng, J., Rathod, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830341/ https://www.ncbi.nlm.nih.gov/pubmed/24251195 http://dx.doi.org/10.4103/2230-8210.119632

Ejemplares similares

Alpha-glucosidase inhibitor, acarbose, improves glycamic control and reduces body weight in type 2 diabetes: Findings on indian patients from the pooled data analysis
por: Kalra, Sanjay, et al.
Publicado: (2013)

On the potential of acarbose to reduce cardiovascular disease
por: Standl, Eberhard, et al.
Publicado: (2014)

Acarbose improves glycemic control as add-on or monotherapy in Indian type-2 diabetes: Findings from the GlucoVIP multinational observational study
por: Philip, Elizabeth, et al.
Publicado: (2013)

Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose
por: Chen, Po-Hsun, et al.
Publicado: (2014)

Acarbose is again on the stage
por: Altay, Mustafa
Publicado: (2022)

Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose
por: Grudén, Stefan, et al.
Publicado: (2021)

Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose
por: Huang, Jie, et al.
Publicado: (2020)

Acarbose Treatment and the Risk of Cardiovascular Disease in Type 2 Diabetic Patients: A Nationwide Seven-Year Follow-Up Study
por: Chen, Jui-Ming, et al.
Publicado: (2014)

Evaluation of the Effects of Acarbose on Weight and Metabolic, Inflammatory, and Cardiovascular Markers in Patients with Obesity and Overweight
por: Khalili, Noushin, et al.
Publicado: (2020)

Evaluation of the Effect of Alogliptin on Tissue Characteristics of the Carotid Wall: Subanalysis of the SPEAD-A Trial
por: Irie, Yoko, et al.
Publicado: (2018)

Biosimilar insulins: Informed choice for South Asia
por: Kalra, Sanjay, et al.
Publicado: (2016)

Evaluation of effect of acarbose consumption on weight losing in non-diabetic overweight or obese patients in Kerman
por: Nakhaee, Akram, et al.
Publicado: (2013)

Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes
por: DiNicolantonio, James J, et al.
Publicado: (2015)

Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset
por: Fernandez, Elizabeth, et al.
Publicado: (2019)

Acarbose improved survival for Apc(+/Min) mice
por: Dodds, Sherry G., et al.
Publicado: (2020)

Evaluation of the Bioequivalence of Acarbose in Healthy Chinese People
por: Chen, Yan, et al.
Publicado: (2021)

Complete biosynthetic pathway to the antidiabetic drug acarbose
por: Tsunoda, Takeshi, et al.
Publicado: (2022)

POS-935 OUTCOME OF COVID-19 IN DIALYSIS PATIENTS IN KELANTAN
por: Fakri, A., et al.
Publicado: (2022)

Continuous treatment with lenalidomide and low‐dose dexamethasone in transplant‐ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial
por: Lu, Jin, et al.
Publicado: (2017)

Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients
por: He, Ke, et al.
Publicado: (2014)

Insulin Glargine and Acarbose in the treatment of elderly patients with diabetes
por: Li, Jing, et al.
Publicado: (2019)

Extension of the Life Span by Acarbose: Is It Mediated by the Gut Microbiota?
por: Wu, Baiyun, et al.
Publicado: (2022)

MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin
por: Wang, Na, et al.
Publicado: (2018)

Effectiveness and safety of fixed dose combination of acarbose/metformin in Indian Type 2 diabetes patients: Results from observational GLOBE Study
por: Saboo, Banshi, et al.
Publicado: (2015)

Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study
por: Ohkuchi, Akihide, et al.
Publicado: (2021)

Obesity in South and Southeast Asia—A new consensus on care and management
por: Tham, Kwang Wei, et al.
Publicado: (2022)

Glycemic management during Jain fasts
por: Julka, Sandeep, et al.
Publicado: (2017)

Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study
por: Du, Guoli, et al.
Publicado: (2020)

Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus
por: Fang, Hui, et al.
Publicado: (2020)

Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
por: Rosak, Christoph, et al.
Publicado: (2012)

Acarbose improves health and lifespan in aging HET3 mice
por: Harrison, David E., et al.
Publicado: (2019)

Method for evaluating the human bioequivalence of acarbose based on pharmacodynamic parameters
por: Xu, Su-Mei, et al.
Publicado: (2020)

A severe leakage of intermediates to shunt products in acarbose biosynthesis
por: Zhao, Qinqin, et al.
Publicado: (2020)

Changes in carotid intima‐media thickening in patients with type 2 diabetes mellitus: Subanalysis of the Sitagliptin Preventive Study of Intima‐Media Thickness Evaluation
por: Mita, Tomoya, et al.
Publicado: (2017)

Gene Cascade Shift and Pathway Enrichment in Rat Kidney Induced by Acarbose Through Comparative Analysis
por: Weng, Chun-Yue, et al.
Publicado: (2021)

Left atrial strain and recurrence of atrial fibrillation after thoracoscopic surgical ablation: a subanalysis of the AFACT study
por: Baalman, Sarah W. E., et al.
Publicado: (2022)

Effects of a novel weight‐loss combination product containing orlistat and acarbose on obesity: A randomized, placebo‐controlled trial
por: Holmbäck, Ulf, et al.
Publicado: (2022)

Addressing self‐monitoring of blood glucose: Advocating paired glycemic testing for people with type 2 diabetes
por: Sheu, Wayne H.‐H.
Publicado: (2012)

A Case of Postprandial Hypotension in the Intensive Care Unit Treated With Acarbose
por: Choi, Joon Hyouk, et al.
Publicado: (2011)

Glycemic equipoise
por: Kalra, Sanjay, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rmt8jaarmeinjdsv1pknpqbhej